Professional
Added to YB: 2024-02-15
Pitch date: 2024-02-14
TLIS [bullish]
Talis Biomedical Corporation
-80.75%
current return
Author Info
Special Situation Investments focuses on event-driven trades and low risk arbitrage opportunities with short term catalysts. Sign up for the newsletter.
Company Info
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States.
Market Cap
$3.1M
Pitch Price
$8.31
Price Target
N/A
Dividend
N/A
EV/EBITDA
1.03
P/E
-0.06
EV/Sales
-93.10
Sector
Health Care Equipment and Supplies
Category
special_situation
Talis Biomedical Corporation Faces Challenges Amidst Downsizing and Litigation, Yet Remains Intriguing Investment Opportunity
$TLIS trades 60% below cash after big downsizing to 10 staff. 76% owned by Baker Bros & Einhorn. Liquidation or reverse merger likely but lawsuit over Covid test EUA nondisclosure a risk. Still attractive post 13% rise since SSI pitch at steep discount to cash.
Read full article (1 min)